Taken together, targeted genetic disruption of ASK1 signaling in adipocytes, but not in myeloid cells, elicits beneficial effects on obesity and obesity-induced insulin resistance. The gene discussed is MAP3K5; the disease is obesity due to melanocortin 4 receptor deficiency.